Mexico Pharmaceuticals and Healthcare Report Q3 2013:Life Sciences Market Research Reports

Life Sciences Market Research Reports

Mexico Pharmaceuticals and Healthcare Report Q3 2013 May 8th 2013, 00:00 BMI View: The improving performance of Mexico’s regulatory system presents more opportunities for multinational pharmaceutical companies seeking to enter the Mexican pharmaceutical market. On the back of favourable economic and political conditions, we forecast Mexico’s pharmaceutical market will grow at a rate of 8.8% in 2013 in local currency terms and 14.4% in US dollar terms. Headline Expenditure Projections ? Pharmaceuticals: MXN176.00bn (US$13.38bn) in 2012 to MXN191.42bn (US$15.31bn) in 2013; +8.8% in local currency terms and +14.4% in US dollar terms. Forecasts decreased from Q213 due to macroeconomic forecast changes. ? Healthcare: MXN957.76bn (US$72.82bn) in 2012 to MXN1,035.09bn (US$82.81bn) in … Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=94979. Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/mexico-pharmaceuticals-and-healthcare-report-q3-2013-market-report.html.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions